Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Gran

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Frontiers in Neurology|July 11, 2022
The Potential for EBV Vaccines to Prevent Multiple SclerosisPeter A Maple, Alberto Ascherio, Jeffrey I Cohen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelinationBruno Gran, Guang-Xian Zhang, Shuo Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytesYaping Yan, Xiaoli Ding, Ke Li, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 21, 2011
Discrepant effects of human interferon-gamma on clinical and immunological disease parameters in a novel marmoset model for multiple sclerosisS Anwar Jagessar, Bruno Gran, Nicole Heijmans, et al.
Frontiers in Microbiology|March 13, 2015
Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosisKatherine W Cook, James Crooks, Khiyam Hussain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 5, 2026
The association between COVID-19 vaccines and bullous pemphigoid risk: A UK population-based studyMikolaj Swiderski, Yana Vinogradova, Matthew J Ridd, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2023
Retraction Notice to: Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS AutoimmunityXing Li, Yuan Zhang, Yaping Yan, et al.
Journal of Clinical & Cellular Immunology|November 19, 2013
Intranasal Delivery of Neural Stem Cells: A CNS-specific, Non-invasive Cell-based Therapy for Experimental Autoimmune EncephalomyelitisShuai Wu, Ke Li, Yaping Yan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2016
RETRACTED: Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS AutoimmunityXing Li, Yuan Zhang, Yaping Yan, et al.
Frontiers in Immunology|March 30, 2018
The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease BiomarkerMd Jakir Hossain, Elena Morandi, Radu Tanasescu, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Frontiers in Neurology|July 11, 2022
The Potential for EBV Vaccines to Prevent Multiple SclerosisPeter A Maple, Alberto Ascherio, Jeffrey I Cohen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelinationBruno Gran, Guang-Xian Zhang, Shuo Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytesYaping Yan, Xiaoli Ding, Ke Li, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 21, 2011
Discrepant effects of human interferon-gamma on clinical and immunological disease parameters in a novel marmoset model for multiple sclerosisS Anwar Jagessar, Bruno Gran, Nicole Heijmans, et al.
Frontiers in Microbiology|March 13, 2015
Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosisKatherine W Cook, James Crooks, Khiyam Hussain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 5, 2026
The association between COVID-19 vaccines and bullous pemphigoid risk: A UK population-based studyMikolaj Swiderski, Yana Vinogradova, Matthew J Ridd, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2023
Retraction Notice to: Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS AutoimmunityXing Li, Yuan Zhang, Yaping Yan, et al.
Journal of Clinical & Cellular Immunology|November 19, 2013
Intranasal Delivery of Neural Stem Cells: A CNS-specific, Non-invasive Cell-based Therapy for Experimental Autoimmune EncephalomyelitisShuai Wu, Ke Li, Yaping Yan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2016
RETRACTED: Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS AutoimmunityXing Li, Yuan Zhang, Yaping Yan, et al.
Frontiers in Immunology|March 30, 2018
The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease BiomarkerMd Jakir Hossain, Elena Morandi, Radu Tanasescu, et al.
Pageof 11